Panchsheel Organics Limited (BOM:531726)

Market Cap	1.61B -3.8%
Revenue (ttm)	1.07B -0.4%
Net Income	108.30M -21.5%
EPS	8.22 -21.5%
Shares Out	13.17M
PE Ratio	14.89
Forward PE	n/a
Dividend	3.20 (2.61%)
Ex-Dividend Date	Jun 12, 2026

Volume	4,503
Open	117.35
Previous Close	117.35
Day's Range	117.35 - 124.90
52-Week Range	86.10 - 184.00
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Panchsheel Organics

Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Org...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 185
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531726

Financial Performance

In fiscal year 2026, Panchsheel Organics's revenue was 1.07 billion, a decrease of -0.37% compared to the previous year's 1.07 billion. Earnings were 108.30 million, a decrease of -21.49%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 10, 2026

Data Sources Report a data error